Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Published on 31 May 2023

A novel signature predicts prognosis and immunotherapy in lung adenocarcinoma based on cancer-associated fibroblasts

in Cancer Immunity and Immunotherapy

Qianhe Ren
Pengpeng Zhang
Haoran Lin
Yanlong Feng
Hao Chi
Xiao Zhang
Zhijia Xia
Huabao Cai
Yue Yu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1201573

14,051 views
55 citations

Correction

Published on 31 May 2023

Corrigendum: Diversity and heterogeneity in human breast cancer adipose tissue revealed at single-nucleus resolution

in Cancer Immunity and Immunotherapy

Lina Tang
Tingting Li
Jing Xie
Yanping Huo
Jianping Ye

Frontiers in Immunology

doi 10.3389/fimmu.2023.1213786

1,115 views

Original Research

Published on 31 May 2023

Sintilimab as maintenance treatment for local/regional recurrent esophageal squamous carcinoma after concurrent chemoradiotherapy: a single-arm Ib/II phase study

in Cancer Immunity and Immunotherapy

Chengxin Liu
Hongfu Sun
Wei Huang
Zhongtang Wang
Chengrui Fu
Dan Han
Qian Zhao
Xue Wu
Baosheng Li

Frontiers in Immunology

doi 10.3389/fimmu.2023.1193394

3,538 views
3 citations

Review

Published on 31 May 2023

Vital roles of m5C RNA modification in cancer and immune cell biology

in Cancer Immunity and Immunotherapy

Xinyu Gu
Xiao Ma
Chao Chen
Jun Guan
Jing Wang
Shanshan Wu
Haihong Zhu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1207371

7,938 views
22 citations

Review

Published on 31 May 2023

The multikinase inhibitor axitinib in the treatment of advanced hepatocellular carcinoma: the current clinical applications and the molecular mechanisms

in Cancer Immunity and Immunotherapy

Hao Jiang
Jian Liao
Liezhi Wang
Chong Jin
Jinggang Mo
Sheng Xiang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1163967

5,243 views
13 citations

Editorial

Published on 31 May 2023

Editorial: Predictive short/long-term efficacy biomarkers and resistance mechanisms of CAR-T immunotherapy treatment

in Cancer Immunity and Immunotherapy

Jiali Cheng
Jin Jin
Liting Chen

Frontiers in Immunology

doi 10.3389/fimmu.2023.1206441

1,430 views
1 citation

Case Report

Published on 30 May 2023

Case Report: An unclassified T cell lymphoma subtype with co-expression of TCR αβ and γ chains revealed by single cell sequencing

in Cancer Immunity and Immunotherapy

Wei Song
Gang Wang
Cheng Wang
Lulu Liu
Liming Zhang
Ruoyu Zhang
Haixi Zhang
Keqian Shi

Frontiers in Immunology

doi 10.3389/fimmu.2023.1184383

3,082 views
1 citation

Review

Published on 30 May 2023

Radiotherapy combined with immune checkpoint inhibitors in locally advanced/metastatic esophageal squamous cell carcinoma: clinical trials, efficacy and future directions

in Cancer Immunity and Immunotherapy

Mengjie Jiang
Yujie Hu
Gang Lin
Chao Chen
Huafeng Li

Frontiers in Immunology

doi 10.3389/fimmu.2023.1177085

6,384 views
14 citations

Original Research

Published on 30 May 2023

Siglec15 is a prognostic indicator and a potential tumor-related macrophage regulator that is involved in the suppressive immunomicroenvironment in gliomas

in Cancer Immunity and Immunotherapy

Jinchao Wang
Linzong Xu
Qian Ding
Xiaoru Li
Kai Wang
Shangchen Xu
Bin Liu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1065062

4,641 views
6 citations

Case Report

Published on 30 May 2023

Successful treatment of severe immune checkpoint inhibitor associated autoimmune hepatitis with basiliximab: a case report

in Cancer Immunity and Immunotherapy

Maiah Zarrabi
Camille Hamilton
Samuel W. French
Noah Federman
Theodore S. Nowicki

Frontiers in Immunology

doi 10.3389/fimmu.2023.1156746

2,731 views
3 citations

Original Research

Published on 30 May 2023

Leveraging a disulfidptosis-based signature to improve the survival and drug sensitivity of bladder cancer patients

in Cancer Immunity and Immunotherapy

Hualin Chen
Wenjie Yang
Yingjie Li
Lin Ma
Zhigang Ji

Frontiers in Immunology

doi 10.3389/fimmu.2023.1198878

15,076 views
79 citations

Review

Published on 30 May 2023

Ferroptosis-mediated immune responses in cancer

in Cancer Immunity and Immunotherapy

Desheng Qi
Milin Peng

Frontiers in Immunology

doi 10.3389/fimmu.2023.1188365

7,940 views
22 citations

Original Research

Published on 30 May 2023

Stapled peptide PROTAC induced significantly greater anti-PD-L1 effects than inhibitor in human cervical cancer cells

in Cancer Immunity and Immunotherapy

Yu-Ying Shi
An-Jin Wang
Xue-Lian Liu
Meng-Yuan Dai
Hong-Bing Cai

Frontiers in Immunology

doi 10.3389/fimmu.2023.1193222

7,410 views
11 citations

Original Research

Published on 30 May 2023

A multifactorial analysis of FAP to regulate gastrointestinal cancers progression

in Cancer Immunity and Immunotherapy

Jialing Cai
Depeng Yang
Handi Sun
Lixing Xiao
Fang Han
Mengmeng Zhang
Lu Zhou
Meiyi Jiang
Qinghua Jiang
Yu Li

Frontiers in Immunology

doi 10.3389/fimmu.2023.1183440

5,027 views
7 citations

Original Research

Published on 29 May 2023

Cost-effectiveness analysis of toripalimab plus chemotherapy versus chemotherapy alone for advanced non-small cell lung cancer in China

in Cancer Immunity and Immunotherapy

Mengdie Zhang
Kai Xu
Yingtao Lin
Chongchong Zhou
Yuwen Bao
Lingli Zhang
Xin Li

Frontiers in Immunology

doi 10.3389/fimmu.2023.1169752

4,415 views
3 citations

Original Research

Published on 29 May 2023

Construction of a fecal immune-related protein-based biomarker panel for colorectal cancer diagnosis: a multicenter study

in Cancer Immunity and Immunotherapy

Hao Zhang
Lugen Zuo
Jing Li
Zhijun Geng
Sitang Ge
Xue Song
Yueyue Wang
Xiaofeng Zhang
Lian Wang
Tianhao Zhao

Frontiers in Immunology

doi 10.3389/fimmu.2023.1126217

4,079 views
5 citations